'Algranati, Oren et al. therefore set out to test whether combining an HDACi known as Vorinostat with a drug that blocks MYC activity (Sulfopin) can act as an effective treatment for this cancer (Diffuse midline gliomas).'

https://elifesciences.org/digests/96257/stronger-together?utm_source=linkedin&utm_medium=social&utm_campaign=organic